KRA_PSY_EATING, excluding more controls

KRA_PSY_EATING_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F50 Hospital discharge: ICD-9 — 3071\|3075[ABE] Hospital discharge: ICD-8 — 30650 Cause of death: ICD-10 — F50 Cause of death: ICD-9 — 3071\|3075[ABE] Cause of death: ICD-8 — 30650 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF12
Parent code in ICD-10: F50-F59
Name in latin: Perturbationes edendi

NAME	KRA_PSY_EATING_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F50
HD_ICD_9	3071\|3075[ABE]
HD_ICD_8	30650
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F50
COD_ICD_9	3071\|3075[ABE]
COD_ICD_8	30650
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to KRA_PSY_EATING, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36341	31953	4251
Only index persons	34663	30911	3752
Unadjusted period prevalence (%)
Whole population	0.82	0.92	0.12
Only index persons	1.03	1.14	0.14
Median age at first event (years)
Whole population	18.09	18.03	18.13
Only index persons	17.90	17.94	17.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4092	3753	339
Unadjusted period prevalence (%)	1.19	1.28	0.15
Median age at first event (years)	22.06	21.24	31.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3664: Matched controls
36591

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F50.3

ICD-10 Finland

Atypical bulimia nervosa

439.9

323.0

659

N06AB06

ATC

sertraline; oral

14.4

323.0

983

906

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

98.0

323.0

922

125

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

175.0

323.0

650

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

15.5

323.0

618

472

F50.2

ICD-10 Finland

Bulimia nervosa

841.8

323.0

945

N05AH04

ATC

quetiapine; oral

28.0

323.0

1593

978

T36

ICD-10 Finland

Poisoning by systemic antibiotics

100.6

323.0

534

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

498.5

323.0

321

N06AX11

ATC

mirtazapine; oral

6.1

323.0

1455

3540

F50.0

ICD-10 Finland

Anorexia nervosa

1911.5

323.0

1082

N05BA04

ATC

oxazepam; oral

8.0

323.0

1368

2547

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

7.6

323.0

888

1470

Z2445

NOMESCO Finland

Psychologist

31.9

323.0

492

177

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

+∞

323.0

429

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

15.2

323.0

1144

1058

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1322.5

323.0

359

N03AX09

ATC

lamotrigine; oral

32.8

323.0

595

215

N06AB03

ATC

fluoxetine; oral

33.4

323.0

1573

804

N06AB10

ATC

escitalopram; oral

6.3

323.0

1370

3149

N05AX12

ATC

aripiprazole; systemic

578.3

323.0

546

F50.1

ICD-10 Finland

Atypical anorexia nervosa

938.0

323.0

809

N05AH03

ATC

olanzapine; systemic

219.8

323.0

607

F50.8

ICD-10 Finland

Other eating disorders

440.5

323.0

566

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

839.1

323.0

378

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

75.6

323.0

735

121

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

639.1

323.0

401

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

52.2

323.0

571

129

N06AB04

ATC

citalopram; systemic

7.6

323.0

1066

1864

N06AX12

ATC

bupropion; oral

19.0

323.0

646

407

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

11.0

323.0

1061

1310

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

236.1

323.0

456

N05AX08

ATC

risperidone; systemic

109.7

323.0

543

F29

ICD-10 Finland

Unspecified nonorganic psychosis

804.5

323.0

364

ZY010

NOMESCO Finland

Hospital outpatient

37.0

323.0

680

224

F50.9

ICD-10 Finland

Eating disorder, unspecified

759.1

323.0

1599

N06AX16

ATC

venlafaxine; oral

14.0

323.0

1115

1107

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1533.1

323.0

409

F32.9

ICD-10 Finland

Depressive episode, unspecified

27.0

323.0

1407

825

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

760.5

323.0

685

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

33.0

323.0

1025

426

IGY99

NOMESCO Finland

Other psychiatric treatment contact

209.3

316.4

325

P86

ICPC

Anorexia nervosa/bulimia

108.9

301.8

328

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2926.6

295.5

282

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

96.6

288.5

318

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

279.3

280.9

284

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

180.6

273.3

284

Z2446

NOMESCO Finland

Social worker

12.3

270.4

514

478

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

14.7

269.4

471

363

N05AA02

ATC

levomepromazine; systemic

228.1

268.8

275

N03AG01

ATC

valproic acid; systemic, rectal

18.5

263.1

419

254

F41.1

ICD-10 Finland

Generalized anxiety disorder

11.2

261.7

522

534

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

19.8

257.7

400

225

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

10.7

250.5

511

544

F34.1

ICD-10 Finland

Dysthymia

33.3

250.0

332

109

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

336.1

248.2

249

F60.9

ICD-10 Finland

Personality disorder, unspecified

374.1

247.6

247

IGY02

NOMESCO Finland

Psychiatric monitoring contact

118.3

244.7

264

P76

ICPC

Depressive disorder

8.6

241.1

562

755

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

79.0

240.6

272

N05CF01

ATC

zopiclone; oral

4.6

240.4

991

2747

Z3231

NOMESCO Finland

Registered nurse

4.0

240.1

1185

3892

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

30.7

236.8

321

114

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

1183.6

230.5

223

N05AN01

ATC

lithium; oral

403.1

230.1

229

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

61.5

229.2

269

N05AF03

ATC

chlorprothixene; systemic

247.1

227.6

232

F61.0

ICD-10 Finland

Mixed personality disorders

242.6

223.4

228

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

76.9

222.0

252

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

218.4

220.0

226

F93.89

ICD-10 Finland

Other childhood emotional disorders

+∞

217.8

207

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

14.8

216.8

376

280

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

290.0

215.6

218

Z3226

NOMESCO Finland

Physiotherapist

4.5

213.3

867

2335

F31.8

ICD-10 Finland

Other bipolar affective disorders

193.6

211.4

219

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

253.2

211.1

215

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

36.0

210.3

274

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

12.2

208.6

396

360

P01

ICPC

Feeling anxious/nervous/tense

3.8

207.8

1073

3591

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

203.9

194

N05AB03

ATC

perphenazine; systemic, rectal

111.2

202.5

220

N06AX21

ATC

duloxetine; oral

7.2

202.0

526

827

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

235.7

196.5

201

N05BA01

ATC

diazepam; systemic, rectal

6.7

194.8

535

904

N06AB05

ATC

paroxetine; oral

11.5

191.7

374

358

F99

ICD-10 Finland

Mental disorder, not otherwise specified

75.8

189.0

215

P03

ICPC

Feeling depressed

4.3

187.9

794

2192

F32.1

ICD-10 Finland

Moderate depressive episode

7.4

187.5

481

736

N05BA06

ATC

lorazepam; systemic, sublingual

31.9

187.3

251

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

15.6

185.1

313

217

ZYC01

NOMESCO Finland

Remote contact by phone

13.2

184.8

337

279

P29

ICPC

Psychological sympt/compl other

6.0

184.7

555

1052

C07AA05

ATC

propranolol; systemic

3.7

182.2

965

3245

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

10.0

182.2

382

419

N05AH02

ATC

clozapine; systemic

+∞

179.5

171

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

14.9

178.0

307

223

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

32.6

177.1

236

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

605.6

176.9

174

F40.1

ICD-10 Finland

Social phobias

17.9

175.3

281

169

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

453.1

175.3

174

F43.1

ICD-10 Finland

Post-traumatic stress disorder

17.7

174.6

281

171

N06AX05

ATC

trazodone; oral

33.5

173.7

230

IER01

NOMESCO Finland

Psychoeducation, group

+∞

173.2

165

N06AX26

ATC

vortioxetine; oral

8.2

171.5

405

543

N91.1

ICD-10 Finland

Secondary amenorrhoea

7.6

171.1

429

631

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1794.9

171.0

165

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

296.1

167.1

169

N03AX16

ATC

pregabalin; oral

4.1

166.0

739

2118

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

105.6

165.6

181

SPAT1240

SPAT

Therapeutic discussion

3.7

162.3

839

2732

N05BE01

ATC

buspirone; oral

52.3

160.9

194

P74

ICPC

Anxiety disorder/anxiety state

8.0

158.4

382

527

E66.8

ICD-10 Finland

Other obesity

6.9

158.2

421

672

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.5

156.9

864

2950

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

26.6

155.9

219

N05CD07

ATC

temazepam; oral

12.1

154.3

292

260

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

9.6

152.8

328

372

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

514.4

150.6

149

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

148.9

142

N06AX03

ATC

mianserin; oral

19.8

146.6

226

121

ZY000

NOMESCO Finland

Hospital inpatient

89.7

146.4

163

F90.0

ICD-10 Finland

Disturbance of activity and attention

11.8

143.7

275

250

P99

ICPC

Psychological disorders other

18.5

142.5

225

129

N07BB01

ATC

disulfiram; oral

30.1

141.4

192

Z2221

NOMESCO Finland

Medical doctor

2.7

141.4

1238

5748

F32

ICD-10 Finland

Depressive episode

6.6

138.3

380

630

R4190

NOMESCO Finland

Nutritional therapy

8.7

136.6

309

382

F39

ICD-10 Finland

Unspecified mood [affective] disorder

32.3

134.3

179

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

132.0

126

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

+∞

129.9

124

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

128.8

123

N05BA12

ATC

alprazolam; oral

6.1

126.1

367

654

F41.00

ICD-10 Finland

Moderate panic disorder

46.5

123.5

152

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

122.5

117

N06BA04

ATC

methylphenidate; oral

13.2

121.7

220

176

F41.09

ICD-10 Finland

UNS Panic Syndrome

12.7

121.1

223

186

SPAT1307

SPAT

Psychosocial counselling and guidance

3.4

120.9

662

2204

N05CF02

ATC

zolpidem; oral

3.5

120.7

640

2077

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

120.0

817

3180

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.3

118.9

693

2416

AA400

NOMESCO Finland

Electroconvulsive therapy

601.2

118.7

117

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1183.8

118.4

115

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

1162.5

116.3

113

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

+∞

116.2

111

F31

ICD-10 Finland

Bipolar affective disorder

392.2

115.1

115

R4140

NOMESCO Finland

Psychotherapy

116.4

114.7

124

N03AE01

ATC

clonazepam; systemic

10.3

112.9

231

238

T05

ICPC

Feeding problem of adult

16.8

110.9

181

113

X78

ICD-10 Finland

Intentional self-harm by sharp object

+∞

108.8

104

N06AX22

ATC

agomelatine; oral

21.4

108.2

162

ZXY60

NOMESCO Finland

2-person team, nurses

+∞

106.7

102

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

106.7

102

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

106.0

1566

9201

F10.09

ICD-10 Finland

Alcohol intoxication UNS

273.1

104.3

106

F50

ICD-10 Finland

Eating disorders

217.8

103.0

106

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

27.0

102.5

143

F10.20

ICD-10 Finland

Alcohol dependence currently independent

346.0

101.6

102

N06AB08

ATC

fluvoxamine; oral

24.5

100.4

144

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

100.4

IBA03

NOMESCO Finland

Psychotherapy evaluation

211.5

99.9

103

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

24.9

99.6

142

IEY01

NOMESCO Finland

Psychoeducation, individual

253.8

97.1

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

205.2

96.8

100

IGV01

NOMESCO Finland

Psychiatric network contact

940.5

94.3

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

19.4

93.2

144

F33

ICD-10 Finland

Recurrent depressive disorder

10.7

92.7

185

181

RD210

NOMESCO Finland

9.4

92.7

198

220

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

41.2

92.2

116

N05AD01

ATC

haloperidol; systemic

41.2

92.2

116

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

+∞

92.0

N06AA12

ATC

doxepin; systemic

14.4

91.8

159

115

N05AE04

ATC

ziprasidone; systemic

+∞

90.9

N06AG02

ATC

moclobemide; oral

13.3

90.8

163

128

R63.0

ICD-10 Finland

Anorexia

55.5

90.7

108

R53

ICD-10 Finland

Malaise and fatigue

2.5

90.5

820

3718

F32.8

ICD-10 Finland

Other depressive episodes

23.4

88.8

129

A02BC02

ATC

pantoprazole; systemic

2.0

88.0

1788

11720

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.3

87.8

350

873

N03AX11

ATC

topiramate; oral

7.2

87.5

222

325

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

856.6

85.9

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.6

85.8

264

498

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

431.8

85.4

G47.3

ICD-10 Finland

Sleep apnoea

3.4

85.2

461

1492

E66.01

ICD-10 Finland

Obesity due to excess calories

3.3

84.9

468

1534

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

84.6

F33.8

ICD-10 Finland

Other recurrent depressive disorders

48.0

84.4

103

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

151.7

84.3

P72

ICPC

Schizophrenia

287.5

82.9

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

42.2

82.4

103

N04AA02

ATC

biperiden; systemic

93.2

82.3

T82

ICPC

Obesity

5.7

81.7

248

460

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

28.1

81.4

112

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

80.5

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

80.5

F60.5

ICD-10 Finland

Anankastic personality disorder

28.3

80.1

110

F51.0

ICD-10 Finland

Nonorganic insomnia

2.8

79.8

577

2275

T08

ICPC

Weight loss

11.9

79.5

150

131

30650

ICD-8 Finland

Special symptoms not elsewhere classified, Feeding disturbance

+∞

79.4

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

143.0

79.2

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

79.2

303

724

P06

ICPC

Sleep disturbance

3.3

77.9

431

1412

R63.4

ICD-10 Finland

Abnormal weight loss

8.7

77.7

173

206

R4110

NOMESCO Finland

Physiotherapy

2.4

77.4

755

3523

G03DB01

ATC

dydrogesterone; oral

2.5

77.3

712

3225

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

77.2

951

4977

N02AX02

ATC

tramadol; systemic, rectal

2.2

77.0

1003

5383

XF400

NOMESCO Finland

ECG with 12 standard connections

3.5

76.8

398

1242

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

5.5

76.5

238

454

F41.8

ICD-10 Finland

Other specified anxiety disorders

6.4

76.2

211

348

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

752.3

75.5

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

752.3

75.5

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

56.9

75.2

IGP01

NOMESCO Finland

Psychiatric family contact

118.1

75.1

A04

ICPC

Weakness/tiredness general

2.5

74.8

654

2873

AA1AD

NOMESCO Finland

CT of head and brain

3.1

74.0

461

1643

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

254.8

73.6

P15

ICPC

Chronic alcohol abuse

28.0

73.4

101

IEV99

NOMESCO Finland

Other psychiatric network intervention

+∞

73.1

ZXY49

NOMESCO Finland

Other health care provider

+∞

73.1

F41.3

ICD-10 Finland

Other mixed anxiety disorders

10.2

72.5

148

151

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

721.1

72.3

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

72.1

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

+∞

71.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

358.5

70.8

E66.9

ICD-10 Finland

Obesity, unspecified

5.0

70.5

240

507

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

700.3

70.3

Z71.8

ICD-10 Finland

Other specified counselling

2.0

68.9

1084

6248

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

679.5

68.2

F60.8

ICD-10 Finland

Other specific personality disorders

95.6

68.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.5

68.0

213

409

A06AD11

ATC

lactulose; oral

3.7

67.8

324

944

R5599

NOMESCO Finland

Other rehabilitation service

9.3

67.6

145

162

E87.6

ICD-10 Finland

Hypokalaemia

12.0

67.4

126

108

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

27.2

67.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.2

66.4

269

677

SPAT1234

SPAT

Support of social functional capacity

8.7

65.3

145

172

H03AA01

ATC

levothyroxine sodium; systemic

2.2

65.2

773

3929

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

65.0

617

2812

SPAT1139

SPAT

Nutrition survey

5.8

64.9

194

352

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.9

63.5

219

469

F10.24

ICD-10 Finland

Alcohol depence active use

627.7

63.0

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

62.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.9

62.5

430

1627

N06AA06

ATC

trimipramine; systemic

15.0

62.0

105

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.4

62.0

320

990

E66.00

ICD-10 Finland

Metabolic syndrome

6.0

61.9

179

312

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

61.6

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

11.3

61.5

118

107

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

65.6

61.5

R51.80

ICD-10 Finland

Headache

2.2

61.2

697

3467

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

60.7

995

5773

N06AA09

ATC

amitriptyline; systemic

4.5

60.7

228

533

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

60.6

753

3892

D01

ICPC

Abdominal pain/cramps general

2.4

59.8

597

2783

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

+∞

59.5

M79.6

ICD-10 Finland

Pain in limb

1.9

59.4

1092

6607

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

6.0

59.3

171

297

103

Kela drug reimbursment

Diabetes, insulin-treated

2.7

59.2

435

1711

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.8

59.0

421

1626

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

127.9

59.0

ZXE20

NOMESCO Finland

More than three and less than five hours

3.1

58.7

345

1173

RF220

NOMESCO Finland

17.2

58.7

N03AX12

ATC

gabapentin; oral

2.9

57.6

373

1354

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

296.0

57.4

R42

ICD-10 Finland

Dizziness and giddiness

2.4

57.3

536

2410

N05AA01

ATC

chlorpromazine; systemic, rectal

152.2

57.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.7

56.8

270

780

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

56.8

900

5129

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

290.7

56.3

R02

ICPC

Shortness of breath/dyspnoea

2.8

55.6

400

1550

X84

ICD-10 Finland

Intentional self-harm by unspecified means

+∞

55.3

R11

ICD-10 Finland

Nausea and vomiting

3.0

55.1

352

1265

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.4

54.8

210

500

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

54.3

540

2501

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

54.3

1111

6937

E66

ICD-10 Finland

Obesity

4.1

54.2

222

563

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

40.7

54.2

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

77.5

54.1

SPAT1389

SPAT

Visit based on need for special support

3.3

53.9

290

923

F21

ICD-10 Finland

Schizotypal disorder

+∞

53.2

S18

ICPC

Laceration/cut

1.9

53.1

1058

6535

SPAT1243

SPAT

Psychiatric/psychological examination

4.2

52.4

209

517

K03.21

ICD-10 Finland

Erosion of teeth due to: persistent vomiting

67.5

52.2

K59.09

ICD-10 Finland

Constipation, unspecified

5.2

51.7

167

332

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

26.1

51.6

L17

ICPC

Foot/toe symptom/complaint

2.0

51.4

821

4667

R06.0

ICD-10 Finland

Dyspnoea

2.2

51.1

619

3139

A02BC01

ATC

omeprazole; systemic

2.0

51.1

745

4083

T90

ICPC

Diabetes non-insulin dependent

3.1

51.1

310

1075

A10BA02

ATC

metformin; oral

2.5

50.5

451

1972

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

50.2

275

887

N05AE05

ATC

lurasidone; oral

+∞

50.1

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

+∞

50.1

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

+∞

50.1

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

+∞

50.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.7

50.0

385

1550

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

50.7

49.9

F98.9

ICD-10 Finland

Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

109.4

49.9

F84.5

ICD-10 Finland

Asperger syndrome

54.4

49.7

C03CA01

ATC

furosemide; systemic

3.0

49.6

315

1126

F60.0

ICD-10 Finland

Paranoid personality disorder

493.6

49.5

N06AX18

ATC

reboxetine; oral

26.0

49.4

C07AB07

ATC

bisoprolol; oral

2.1

49.4

694

3741

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

18.2

49.3

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

70.8

49.1

R4120

NOMESCO Finland

Occupational therapy

4.1

49.1

199

500

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

49.0

ZXY59

NOMESCO Finland

2-person team, nurse-other special worker

+∞

49.0

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

+∞

49.0

L03

ICPC

Low back symptom/complaint

1.9

48.9

880

5214

P80

ICPC

Personality disorder

91.2

48.9

N05BA02

ATC

chlordiazepoxide; systemic

29.1

48.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.4

48.2

182

427

K59.0

ICD-10 Finland

Constipation

4.2

48.0

193

481

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

+∞

48.0

ZXY56

NOMESCO Finland

2-person team, nurse-psychologist

+∞

48.0

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

13.6

47.9

N05AF01

ATC

flupentixol; systemic

34.9

47.9

Z72.2

ICD-10 Finland

Drug use

105.3

47.8

F45.8

ICD-10 Finland

Other somatoform disorders

2.4

47.6

430

1889

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

47.6

708

3899

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

473.0

47.4

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.4

47.1

147

281

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3018418) pH of Serum or Plasma

1343

4676

3.77

318.46

3.9

3.2

7.4

0.87

230

902

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

792

1326

7.14

307.65

3.1

2.6

g/l

0.2

0.49

721

1261

(3012095) Magnesium [Moles/volume] in Serum or Plasma

933

2430

4.66

307.65

3.8

3.3

mmol/l

0.8

0.07

872

2302

(3003458) Phosphate [Moles/volume] in Serum or Plasma

997

1803

6.97

307.65

6.0

5.3

mmol/l

1.1

3.00

923

1705

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1904

7441

3.90

307.65

6.5

4.4

mmol/l

1.2

2.83

1759

6786

(3021960) Folate [Moles/volume] in Serum or Plasma

1188

3664

4.15

307.65

1.7

1.3

nmol/l

21.7

21.2

0.55

1077

3283

(3019309) Folate [Moles/volume] in Red Blood Cells

960

2091

5.67

307.65

1.9

1.6

nmol/l

1156.8

1193.4

0.53

772

1619

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1920

7123

4.18

307.65

2.2

1.5

pmol/l

97.4

98.8

0.62

1112

3963

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2280

10668

3.56

307.65

2.9

2.0

nmol/l

71.2

72.8

2.16

2116

10089

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2059

8561

3.82

307.65

7.1

4.8

mmol/l

1.2

0.41

1776

7264

(3024561) Albumin [Mass/volume] in Serum or Plasma

1892

7900

3.58

307.65

4.8

4.2

g/l

37.7

37.1

5.10

1749

7388

(3015377) Calcium [Moles/volume] in Serum or Plasma

1757

5930

4.43

307.65

2.8

mmol/l

2.3

0.85

1571

5388

(3028707) Methadone [Presence] in Urine by Screen method

557

345

18.47

307.65

3.2

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1194

2954

5.28

307.65

2.2

1.3

1.4

1.2

48.62

1062

2724

(3011288) Drugs identified in Urine by Screen method

680

1289

6.11

307.65

3.6

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

174

40.21

285.09

6.0

3.8

umol/l

369.1

334.0

0.71

144

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1751

8064

3.04

251.83

3.6

2.6

u/l

28.3

27.6

0.25

1653

7739

(1001926) Buprenorphine [Presence] in Urine by Screen method

661

1677

4.49

238.22

3.0

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2917

18085

3.12

237.06

7.2

5.5

u/l

71.7

70.5

0.88

2744

16970

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1482

6515

2.99

227.33

2.6

2.0

mg/l

2.7

2.5

1.59

1263

5637

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

106

18.07

225.95

1.9

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

829

2692

3.60

209.57

2.3

mmol/l

2.4

0.49

706

2321

(3009508) Creatinine [Moles/volume] in Urine

1225

5035

3.03

209.50

3.7

3.0

mmol/l

7.4

8.2

4.60

1031

4494

(3016879) Cocaine [Presence] in Urine

708

2156

3.75

196.31

3.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

724

2250

3.68

194.66

2.0

nmol/l

396.3

393.7

0.11

650

2102

(3044889) 12 lead EKG panel

2439

14704

2.62

191.22

3.6

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1447

6778

2.75

190.87

3.2

2.0

u/l

57.9

57.5

0.08

1299

6318

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

114

40.28

187.10

4.5

1.4

umol/l

180.2

138.6

0.19

(4198724)

129

26.52

186.52

3.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

740

2453

3.45

179.18

3.1

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3517

25990

3.50

178.81

5.8

3.7

pmol/l

13.8

14.3

30.05

3288

23898

(3028300) Cannabinoids [Presence] in Urine

741

2489

3.40

175.44

3.1

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1934

10801

2.49

172.97

4.9

4.4

umol/l

9.4

10.0

1.44

1764

10077

(3027008) Opiates [Presence] in Urine

735

2486

3.37

171.86

3.1

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2528

16153

2.47

164.87

11.3

6.3

e9/l

3.8

3.9

3.50

2200

14277

(3019550) Sodium [Moles/volume] in Serum or Plasma

3671

28353

3.85

162.85

15.4

6.4

mmol/l

139.3

139.4

2.01

3585

27253

(3006315) Basophils [#/volume] in Blood

2283

13994

2.42

162.63

7.0

5.1

e9/l

0.0

1.65

1978

12467

(3023103) Potassium [Moles/volume] in Serum or Plasma

3675

28426

3.86

162.14

15.5

6.5

mmol/l

3.9

1.43

3579

27244

(3001604) Monocytes [#/volume] in Blood

2275

13936

2.41

162.11

7.0

5.0

e9/l

0.5

3.90

1975

12444

(42870588) Differential panel, method unspecified - Blood

1605

8426

2.48

161.69

6.4

5.5

—

(3013115) Eosinophils [#/volume] in Blood

2341

14586

2.40

159.54

7.8

5.1

e9/l

0.2

6.35

2072

13203

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1737

9537

2.42

157.41

1.6

1.3

u/ml

1.0

1.5

2.79

455

2814

(3019198) Lymphocytes [#/volume] in Blood

2355

14852

2.37

154.03

6.9

4.9

e9/l

1.9

2.0

3.26

2091

13524

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1038

4508

2.74

154.02

2.4

1.8

u/l

234.5

173.2

0.28

988

4280

(3013826) Glucose [Moles/volume] in Serum or Plasma

2284

14268

2.35

151.98

5.4

3.4

mmol/l

6.0

6.1

0.09

2097

12022

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

918

3789

2.82

149.83

1.8

1.4

pmol/l

435.3

41162866.5

4.32

794

3355

(3027944) Amphetamines [Presence] in Urine

698

2483

3.17

148.72

3.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

243

383

6.66

147.47

1.3

1.1

—

(3022096) Basophils/100 leukocytes in Blood

2083

12692

2.30

144.53

7.2

5.2

0.7

0.07

1934

11922

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3731

29832

3.82

141.00

6.9

4.1

mu/l

1.7

1.8

1.55

3573

28245

(3019069) Monocytes/100 leukocytes in Blood

2151

13377

2.27

140.84

7.3

5.2

7.8

0.37

2015

12666

(3006504) Eosinophils/100 leukocytes in Blood

2139

13274

2.27

140.75

7.0

5.1

2.6

2.8

4.10

1989

12448

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2762

19112

2.36

139.12

3.8

2.8

ug/l

53.7

55.9

0.49

2597

18235

(3021447) Carbon dioxide [Partial pressure] in Venous blood

439

1213

3.92

137.97

6.1

3.9

kpa

6.0

5.7

6.44

431

1177

(3014576) Chloride [Moles/volume] in Serum or Plasma

502

1537

3.57

135.58

7.1

6.2

mmol/l

104.6

105.4

3.44

494

1505

(3002032) Base excess in Venous blood by calculation

430

1211

3.84

131.32

6.2

3.9

mmol/l

1.7

1.5

0.26

356

958

(3002030) Lymphocytes/100 leukocytes in Blood

2227

14310

2.21

131.15

7.0

4.9

30.8

30.6

0.27

2090

13512

(3022948) Iron [Moles/volume] in Serum or Plasma

783

3171

2.81

130.91

2.5

2.0

umol/l

14.0

14.9

2.70

729

2970

(3018010) Neutrophils/100 leukocytes in Blood

2200

14115

2.20

129.45

6.9

4.8

55.4

55.8

0.87

2065

13384

(3013707) Erythrocyte sedimentation rate by Westergren method

2899

20807

2.34

128.88

4.0

3.3

mm/h

9.1

8.4

3.31

2712

19495

(3007164) IgA [Mass/volume] in Serum or Plasma

1445

7837

2.30

128.87

1.5

1.4

g/l

1.9

2.0

0.52

811

5215

(40758558) Short blood count panel - Blood

1201

6131

2.35

122.38

7.3

5.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3393

26362

2.66

122.34

4.4

2.5

mmol/l

5.6

5.4

6.36

3172

24779

(3004789) Transferrin [Mass/volume] in Serum or Plasma

700

2811

2.79

118.00

2.5

2.0

g/l

2.5

0.05

634

2632

(3024354) Oxygen [Partial pressure] in Venous blood

370

1028

3.84

114.79

5.4

3.6

kpa

4.8

4.7

0.22

361

995

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2859

20874

2.21

114.61

3.9

2.2

u/l

29.3

27.7

1.25

2702

20098

(3033658) Prothrombin time (PT) actual/Normal

1070

5365

2.34

112.26

4.4

3.0

97.1

97.0

0.06

1035

5197

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

299

727

4.34

111.24

7.2

4.5

mmol/l

24.2

24.0

0.48

275

677

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3370

26529

2.52

110.32

11.4

6.0

ml/min/173m2

101.1

98.8

7.93

2647

20611

(3020191) Ethanol [Moles/volume] in Serum or Plasma

102

13.52

108.08

1.7

1.1

promille

1.1

1.2

0.27

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

626

2495

2.77

106.33

2.6

2.1

21.9

24.4

4.16

550

2171

(3014111) Lactate [Moles/volume] in Serum or Plasma

372

1100

3.61

105.07

7.9

6.5

mmol/l

1.2

1.3

0.51

350

1065

(3000991) Gas panel - Venous blood

377

1143

3.52

102.43

10.0

7.3

—

(3021589) Normoblasts [#/volume] in Blood

2009

13251

2.01

100.56

9.9

6.8

e9/l

0.0

1.41

1610

11010

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

505

1892

2.89

95.85

2.7

2.0

u/l

31.6

37.6

1.16

428

1624

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3827

32816

3.54

93.62

10.8

6.4

u/l

24.3

23.2

1.31

3713

31672

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

310

914

3.58

87.59

4.9

3.2

kpa

5.2

5.0

5.98

291

857

(3008295) Osmolality of Serum or Plasma

112

134

8.54

86.37

3.7

1.8

mosm/kgh2o

284.2

287.4

0.91

109

(3013512) EKG study

867

4389

2.23

86.09

3.2

2.2

—

(3009343) pH of Capillary blood

306

906

3.56

85.88

4.8

3.2

7.4

1.88

103

(3030467) Casts [#/volume] in Urine by Automated count

1115

6240

2.07

85.36

3.3

2.4

e6/l

0.2

0.24

806

4427

(3048689) Calprotectin [Mass/mass] in Stool

956

5093

2.14

83.10

2.5

2.6

ug/g

82.1

100.0

1.13

708

4033

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

296

884

3.52

81.91

4.9

3.3

mmol/l

1.5

1.1

0.92

204

584

(3023368) Bacteria identified in Blood by Culture

844

4313

2.20

81.39

4.5

3.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

190

413

4.76

81.09

1.3

ug/g

318.8

321.0

0.04

200

(3021387) Prolactin [Units/volume] in Serum or Plasma

657

3036

2.38

80.45

1.8

1.5

mu/l

358.4

284.0

3.49

569

2713

(40768797) Stomach Pathology biopsy report

601

2669

2.46

80.39

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1194

6985

1.99

79.94

3.5

2.4

e6/l

131.9

77.3

0.31

883

5033

(36304419) Bacteria [Presence] in Urine

1117

6394

2.02

79.46

3.3

2.3

—

(3026782) Osmolality of Urine

835

4307

2.17

78.34

2.9

2.2

mosm/kgh2o

518.5

552.2

3.21

701

3588

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2863

22377

1.92

76.16

5.0

3.2

mmol/mol

37.4

36.3

6.37

2665

21340

(3018095) Leukocytes [#/volume] in Urine

1485

9508

1.87

74.78

4.1

2.8

e6/l

67.0

69.0

0.05

947

5671

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1071

6167

1.99

74.13

3.0

2.1

ng/l

25.3

28.4

0.20

437

2022

(36660697) Celiac disease serology panel - Serum

659

3159

2.29

73.63

1.3

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

+∞

71.99

1.9

0.0

nmol/l

153.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

414

1630

2.70

70.64

3.3

2.9

1.6

0.20

346

1471

(3020779) Urea [Moles/volume] in Serum or Plasma

324

1133

3.01

68.91

7.6

6.5

mmol/l

6.2

6.4

0.27

311

1091

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

492

2158

2.45

66.96

2.9

3.7

pmol/l

4.3

4.7

16.91

428

1985

(3032080) INR in Blood by Coagulation assay

1073

6435

1.90

64.41

5.7

3.9

inr

1.1

0.03

381

2413

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

664

3358

2.16

64.37

3.0

2.2

e6/l

4.7

4.8

0.03

313

1731

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

512

2343

2.35

63.17

2.6

2.5

umol/l

5.8

6.0

0.08

405

1972

(3019225) pH of Specimen

374

1482

2.67

62.78

4.5

2.7

—

(3042936) Bacteria identified in Isolate by Culture

577

2788

2.24

62.55

2.0

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

233

709

3.41

62.40

5.7

3.4

g/l

128.3

130.8

1.00

227

694

(3003396) Base excess in Arterial blood by calculation

337

1271

2.79

62.27

7.3

6.4

mmol/l

0.8

0.3

1.12

270

910

(3009214) Lutropin [Units/volume] in Serum or Plasma

443

1922

2.46

61.52

1.7

1.3

u/l

7.4

8.9

2.16

354

1633

(3027801) Oxygen [Partial pressure] in Arterial blood

333

1262

2.77

60.93

7.4

6.5

kpa

12.8

14.7

6.47

318

1206

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

333

1262

2.77

60.93

7.4

6.5

kpa

5.2

4.9

6.88

319

1205

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

670

3469

2.11

60.83

2.8

2.1

e6/l

1.0

1.2

0.38

321

1847

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

288

1017

2.96

60.04

4.1

3.5

ng/l

75.9

65.3

0.99

256

946

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

914

5309

1.92

59.88

1.7

1.5

mmol/l

1.3

1.2

4.50

799

4711

(3000850) Epithelial cells [#/volume] in Urine

837

4731

1.96

59.41

2.8

2.1

e6/l

9.3

9.0

0.19

727

4027

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

185

500

3.82

59.17

6.2

3.4

0.6

0.7

0.88

180

487

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3716

32801

2.42

58.90

14.0

7.6

mg/l

18.2

19.4

1.45

2815

24365

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

632

3245

2.11

58.49

2.0

1.8

—

(3016502) Oxygen saturation in Arterial blood

296

1079

2.87

58.21

7.6

6.9

95.3

97.1

2.71

288

1035

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

586

2943

2.15

57.36

1.8

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

326

1267

2.70

56.72

1.9

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2824

22860

1.75

56.71

4.7

3.5

—

(3022313) Gas panel - Capillary blood

211

646

3.38

55.91

5.5

3.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

544

2682

2.18

55.72

3.0

2.6

ng/l

982.3

544.9

0.50

417

2134

(3052851) Hemolysis interference index of Serum or Plasma

182

516

3.63

54.26

2.9

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1608

11324

1.68

53.54

2.6

2.0

—

(3019150) Specific gravity of Urine by Refractometry

1041

6496

1.80

53.45

3.7

2.9

kg/l

1.0

0.92

126

1151

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1748

12603

1.67

53.04

2.8

2.1

—

(3026008) Bacteria identified in Urine by Culture

1293

8627

1.72

52.35

2.8

2.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

992

6139

1.81

52.18

2.3

1.7

mg/l

0.9

1.0

0.34

664

4450

(3023183) Ammonium ion [Moles/volume] in Plasma

172

5.73

52.05

2.7

3.1

umol/l

31.0

34.6

0.52

153

(3007853) Bacteria identified in Skin by Aerobe culture

569

2935

2.08

51.58

2.0

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

311

1247

2.61

50.72

1.7

1.5

nmol/l

0.3

0.5

8.71

250

1062

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

416

1917

2.29

49.99

6.8

3.5

—

(3024928) Oxygen saturation in Venous blood

114

243

4.78

49.76

7.2

4.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2744

22393

1.67

49.64

5.1

3.4

e6/l

242.4

1210.7

2.43

236

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

315

1284

2.57

49.64

3.6

2.7

mmol/l

1.2

0.38

270

1106

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

396

1794

2.33

49.51

1.7

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

131

316

4.24

48.96

2.9

2.2

mmol/l

24.3

23.6

1.13

114

282

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3255

27875

1.80

48.94

3.9

2.8

mmol/l

2.7

2.8

13.52

3031

26529

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

185

570

3.34

48.49

8.7

9.1

mmol/l

24.4

23.9

0.94

170

549

(3037522) Nuclear Ab [Titer] in Serum

730

4194

1.89

48.31

1.4

titre

428.7

670.8

3.20

113

855

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

385

1744

2.33

48.10

1.7

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

489

2459

2.12

47.19

1.5

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

345

1504

2.40

47.00

1.1

u/ml

0.9

1.8

—

(3012516) Albumin [Mass/volume] in Urine

662

3732

1.92

46.25

3.8

3.5

mg/l

364.5

283.7

0.18

427

2528

(3006653) Thiamine [Moles/volume] in Blood

8.41

46.11

1.3

1.4

nmol/l

137.5

128.3

0.57

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3230

27762

1.76

45.87

3.8

2.7

mmol/l

4.6

4.7

13.21

3048

26622

(1616796) Gas panel - Central venous blood

124

302

4.19

45.76

3.3

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

3377

29416

1.83

45.68

19.2

9.0

13.3

0.28

3322

28788

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

191

624

3.15

45.46

5.9

3.6

mmol/l

24.4

24.3

0.17

186

594

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

226

813

2.87

45.40

1.6

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

680

3905

1.88

44.76

4.7

4.2

mg/mmol

10.7

13.2

0.57

438

2697

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3088

26398

1.68

42.56

3.4

2.5

mmol/l

1.2

1.1

5.69

2873

25374

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3197

27600

1.71

42.24

3.7

2.7

mmol/l

1.5

1.22

2992

26444

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

534

2917

1.95

40.63

3.5

2.4

ng/l

403.2

484.5

0.11

236

1314

(3000494) Fungus identified in Specimen by Culture

500

2690

1.97

39.72

1.5

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

127

351

3.69

39.32

1.9

2.3

ug/l

216.9

253.4

0.18

102

299

(3042517) Benzodiazepines panel - Urine

84.66

37.78

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

550

3115

1.88

37.31

1.6

1.3

iu/l

15.4

18.4

1.79

448

2702

(3023520) Reticulocytes [#/volume] in Blood

251

1052

2.47

37.13

3.1

2.7

e9/l

67.8

70.3

0.45

167

743

(3018677) aPTT in Platelet poor plasma by Coagulation assay

502

2777

1.91

36.57

3.7

2.4

29.6

29.3

0.49

479

2676

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

811

5184

1.70

36.34

2.6

2.2

u/l

6520.6

7034.9

0.17

289

2368

(3017143) Hepatitis C virus Ab [Presence] in Serum

942

6295

1.64

35.45

1.9

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

814

5277

1.67

34.36

1.4

1.2

iu/ml

66.0

21.8

0.42

197

1604

(3028626) Oxygen [Partial pressure] in Capillary blood

144

470

3.13

34.33

6.4

3.9

kpa

9.2

9.5

1.11

132

444

(40761511) CBC panel - Blood by Automated count

3823

35403

2.18

33.47

14.0

7.2

—

(3019060) Gas panel - Arterial blood

174

645

2.76

33.01

4.5

3.9

—

(3010421) pH of Blood

122

369

3.37

32.95

4.3

2.3

7.4

1.15

104

309

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

770

4991

1.66

32.31

1.3

1.2

u/ml

14.7

8.9

0.37

258

2168

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1173

8412

1.55

32.17

2.5

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

290

1377

2.18

32.05

1.6

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

205

838

2.51

31.96

2.1

1.8

ug/l

5.3

5.8

0.15

173

730

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

464

2613

1.87

31.78

1.1

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1005

6999

1.57

31.24

3.5

2.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

286

1365

2.17

31.19

1.9

1.6

—

(3012501) Base excess in Blood by calculation

108

313

3.51

31.18

4.2

2.2

mmol/l

2.2

2.1

0.08

150

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

956

6588

1.58

31.08

2.2

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

213

904

2.42

30.62

1.7

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

602

3706

1.73

30.47

1.3

1.2

iu/ml

91.4

157.3

4.99

173

1513

(3003181) Sodium [Moles/volume] in Urine

135

4.94

30.31

2.2

1.6

mmol/l

64.2

72.5

0.49

117

(40767503) Oxygen content in Capillary blood by calculation

273

3.64

30.04

3.1

2.0

17.2

17.5

0.28

129

(3022145) Colonoscopy Study observation

439

2496

1.84

29.05

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

201

853

2.42

28.90

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

281

3.54

28.78

2.4

2.1

nmol/l

21.3

23.3

0.94

272

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

322

1660

2.01

28.57

1.6

1.5

mg/l

3.5

3.8

0.19

237

980

(3022217) INR in Platelet poor plasma by Coagulation assay

280

1374

2.11

28.39

12.9

10.2

inr

1.1

0.02

271

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

645

2.61

28.22

9.1

8.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

250

1178

2.19

28.12

1.9

1.5

nmol/l

6.3

6.1

0.10

208

1046

(42529406) Shigella sp [Presence] in Stool by Culture

200

859

2.39

28.00

1.2

1.1

—

(3020891) Body temperature

120

400

3.05

27.64

6.3

3.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

347

1868

1.93

27.14

2.2

2.6

g/l

9.9

10.7

5.22

315

1737

(3021901) Oxygen saturation in Capillary blood

204

3.92

27.02

2.9

2.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

848

2.37

27.00

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

343

1844

1.93

26.93

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

409

2331

1.83

26.78

1.2

titre

20.8

239.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

182

774

2.41

26.05

2.3

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

753

5124

1.57

25.21

2.2

2.1

umol/l

2090.0

2825.0

0.34

654

4661

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

+∞

24.99

5.1

0.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1066

7827

1.48

24.95

4.8

3.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

253

1266

2.06

24.32

1.6

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

274

1412

2.00

24.28

1.6

1.8

g/l

1.2

1.4

3.89

253

1331

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

335

1857

1.87

23.89

3.4

2.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1991

16472

1.40

23.86

3.7

2.8

estimate

0.0

1.15

384

3445

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

196

896

2.24

23.75

1.5

1.4

u/l

13.3

15.8

0.83

171

775

(3035637) Corticotropin [Mass/volume] in Plasma

317

3.07

22.53

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

177

3.82

22.24

1.7

1.4

umol/l

20.3

25.7

0.78

172

(3009261) Glucose [Presence] in Urine by Test strip

1999

16682

1.38

22.04

3.8

2.8

estimate

0.0

0.21

390

3515

(3021601) Nitrite [Presence] in Urine by Test strip

1986

16572

1.38

21.83

5.1

3.9

estimate

0.0

1.08

399

3579

(3007461) Platelets [#/volume] in Blood

3984

38198

2.56

20.88

23.9

11.1

e9/l

268.1

265.1

2.39

3921

37296

(3023410) Appearance of Cerebral spinal fluid

253

3.24

20.88

1.4

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

105

381

2.79

20.83

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

347

2.86

20.35

3.6

2.9

mu/l

29.2

24.1

0.47

324

(3043409) Potassium [Moles/volume] in Arterial blood

296

3.01

20.04

4.5

3.4

mmol/l

3.8

0.24

271

(3026361) Erythrocytes [#/volume] in Blood

3985

38256

2.52

20.03

23.9

11.1

e12/l

4.4

4.5

10.63

3911

37329

(3035941) MCH [Entitic mass]

3984

38245

2.51

19.97

23.8

11.0

29.9

29.8

1.79

3956

37834

(3024731) MCV [Entitic volume]

3984

38250

2.50

19.88

23.8

11.0

89.8

89.2

11.41

3956

37838

(3044290) Cell count panel - Cerebral spinal fluid

127

521

2.48

19.72

1.2

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

185

891

2.12

19.69

1.5

2.4

g/l

66.3

67.8

2.14

167

837

(3010813) Leukocytes [#/volume] in Blood

3984

38277

2.47

19.36

24.0

11.1

e9/l

6.6

6.8

11.66

3913

37316

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

241

3.18

19.14

1.2

—

30.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

3984

38290

2.46

19.11

24.1

11.1

g/l

131.6

133.0

13.16

3956

37877

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.88

19.06

1.1

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

233

1239

1.93

18.84

1.2

1.3

u/ml

0.2

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

270

3.03

18.76

1.4

1.7

g/l

0.0

0.49

255

(3007566) Smooth muscle Ab [Titer] in Serum

142

627

2.30

18.72

1.2

1.4

titre

47.1

100.6

1.91

(3017181) Myelocytes/100 leukocytes in Blood

329

1951

1.74

18.67

4.2

3.9

0.7

0.03

409

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

129

547

2.39

18.65

1.2

1.5

e6/l

13.6

23.0

0.64

101

433

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

547

2.39

18.65

1.3

1.6

e6/l

313.3

1613.1

0.79

108

452

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

166

785

2.15

18.53

2.3

2.6

ng/l

58.5

88.2

1.73

135

690

(3025941) Bacteria identified in Stool by Culture

337

2019

1.72

18.44

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

319

1885

1.74

18.33

4.3

3.9

0.1

0.2

0.82

385

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

282

1617

1.79

17.96

1.5

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

368

2280

1.67

17.76

3.6

2.5

34.0

33.8

0.09

287

1747

(3009542) Hematocrit [Volume Fraction] of Blood

3572

33378

1.53

17.56

17.2

8.0

39.2

39.6

3.98

2913

28386

(3011648) Oxygen content in Venous blood

102

4.34

17.45

2.6

7.4

10.9

11.0

0.09

102

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

129

566

2.31

17.29

6.3

5.5

mg/l

1.2

1.1

0.66

115

540

(3044640) Blood type and Crossmatch panel - Blood

1206

9553

1.37

17.19

2.3

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

323

2.75

17.14

1.4

1.7

g/l

2.9

3.0

0.45

263

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

291

2.85

17.01

1.4

1.8

g/l

0.1

0.4

1.10

265

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2.69

16.94

1.7

g/l

7.2

0.04

271

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

331

2.72

16.91

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

125

547

2.32

16.86

1.1

1.4

mmol/l

3.6

3.5

0.66

116

517

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

332

2.71

16.81

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

304

1816

1.72

16.79

3.6

3.8

0.4

0.5

0.70

307

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

463

2.43

16.68

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

324

1977

1.69

16.55

2.3

2.2

au/ml

17.1

19.4

0.22

175

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

185

951

1.98

16.53

1.9

g/l

1.1

0.32

178

908

(46235355) HIV 1 and 2 tests - Meaningful Use set

1932

16480

1.32

16.45

2.5

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2.66

16.41

1.7

g/l

3.5

3.8

1.30

247

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2.66

16.41

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

136

624

2.21

16.40

1.2

1.4

mg/l

357.9

460.6

2.50

129

600

(3025159) Blasts/100 leukocytes in Blood

303

1820

1.71

16.40

4.4

4.0

0.0

0.6

0.97

327

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

141

657

2.18

16.37

2.2

2.1

g/l

1.2

0.02

121

581

(40761535) Cells panel - Urine sediment

272

1587

1.76

16.33

3.4

2.8

—

(3036489) Thrombin time

209

1125

1.90

16.30

3.0

2.3

20.5

20.9

0.93

164

922

(3021879) Hepatitis B virus core Ab [Presence] in Serum

574

4021

1.49

16.20

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

180

926

1.98

16.05

1.9

g/l

0.2

0.19

173

884

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

237

1337

1.81

15.94

1.1

u/ml

4.7

4.2

0.13

226

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

247

2.94

15.91

1.4

1.7

g/l

0.0

0.00

233

(21494755) Public health laboratory ask at order entry panel

373

5597

0.63

15.80

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

244

2.93

15.64

1.4

1.7

g/l

0.0

0.00

232

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

317

2.68

15.54

1.7

g/l

9.2

10.6

2.60

281

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

103

4.10

15.52

1.6

1.4

nmol/l

0.1

0.3

2.15

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

276

4409

0.60

15.19

1.6

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

1212

1.83

15.09

1.6

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

917

7077

1.38

15.05

2.3

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

269

2.77

14.73

1.4

1.7

g/l

39.2

39.4

0.13

236

(3004588) Protein electrophoresis panel - Serum or Plasma

133

632

2.13

14.73

1.6

1.8

—

(40768804) Tissue Pathology biopsy report

1423

11758

1.32

14.71

2.0

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

204

1135

1.83

14.37

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

298

1849

1.65

14.27

1.2

au/ml

18.7

28.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

306

1926

1.63

13.84

3.5

3.9

u/l

210.8

233.0

2.71

282

1846

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

429

2.33

13.72

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

197

3.01

13.71

1.7

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

500

2.23

13.63

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

3.33

13.17

2.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

5.10

13.08

3.6

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

258

2.65

12.52

1.3

1.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

122

3.46

12.27

1.4

u/l

5.9

6.0

0.00

100

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.20

12.21

1.2

ng/l

8.8

69.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

373

2.33

11.95

2.2

1.8

ug/l

2.2

2.0

0.07

330

(40768443) Skin Pathology biopsy report

168

934

1.83

11.91

1.2

—

(1002224) Polysomnography panel

182

1037

1.78

11.89

1.1

—

(4010399)

224

1360

1.68

11.67

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

181

1037

1.77

11.62

5.8

2.6

97.3

93.2

1.65

157

945

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

3.53

11.48

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

11.45

1.5

0.0

nmol/l

369.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

733

9234

0.75

11.34

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1485

12658

1.27

11.23

1.9

1.8

—

(3003338) MCHC [Mass/volume]

3313

31079

1.33

11.15

19.8

9.1

g/l

331.9

332.9

8.56

3290

30795

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

5.53

11.11

1.9

2.9

umol/l

22.4

27.3

0.58

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

434

2.16

10.88

4.4

5.4

iu/ml

348.8

413.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

171

986

1.76

10.76

2.7

2.6

155.5

160.5

0.38

156

934

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

3.24

10.59

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

251

2.53

10.57

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

158

896

1.79

10.53

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

247

2.53

10.41

1.1

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

10.41

2.2

0.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

397

2.18

10.35

4.1

2.2

nmol/l

1.0

0.7

1.39

346

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

104

517

2.03

10.33

1.3

1.5

—

6.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

248

2.51

10.33

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

249

2.50

10.24

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

249

2.50

10.24

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

485

2.06

10.23

1.2

umol/l

5.9

6.5

1.17

461

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

250

2.49

10.16

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

251

3741

0.65

10.04

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

321

4553

0.68

10.03

1.5

1.6

—

(4146454)

3.60

10.02

3.1

3.3

—

(3051611) Lipemic interference index of Serum or Plasma

161

2.87

9.93

3.3

2.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

259

2.45

9.92

1.7

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

6.07

9.87

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

260

2.44

9.84

1.7

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

279

2.38

9.78

1.2

1.5

76.1

72.5

1.80

269

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.13

9.78

1.5

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.13

9.78

1.5

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

261

2.43

9.76

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

261

2.43

9.76

1.7

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

288

2.34

9.58

13.0

5.6

u/ml

0.4

0.19

136

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.59

9.48

2.2

2.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

261

2.39

9.30

1.7

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

312

2162

1.47

9.17

1.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

269

2.36

9.16

1.2

1.5

mu/l

535.6

446.4

0.36

259

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

270

2.35

9.08

1.7

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

158

936

1.71

9.08

1.6

2.1

u/l

39.7

39.0

0.17

141

889

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

234

2.45

9.03

1.4

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.97

8.99

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

136

776

1.77

8.93

1.2

1.3

u/ml

1.9

3.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

468

6108

0.73

8.92

1.5

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.19

8.86

1.3

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

324

2.21

8.85

2.8

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

4.65

8.77

1.6

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

969

1.68

8.74

1.8

2.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

185

2.60

8.68

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

239

2.40

8.65

3.1

2.7

1.1

1.5

0.70

187

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

325

4474

0.70

8.56

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

193

2.55

8.49

2.8

3.1

mg/l

30.8

40.9

0.63

160

(3035320) C reactive protein [Mass/volume] in Body fluid

205

2.50

8.47

2.4

1.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

19.99

8.45

1.2

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

159

2.71

8.44

1.1

mg/l

292.6

309.4

0.60

149

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

182

2.59

8.43

1.1

1.4

—

568.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

182

2.59

8.43

1.1

1.4

titre

88.6

272.9

—

(3028433) Virus identified in Specimen by Culture

3.67

8.39

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

144

851

1.71

8.38

1.4

1.3

u/ml

221.4

230.7

0.19

536

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

792

1.74

8.34

1.2

1.3

u/ml

15.2

14.0

—

141

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

227

2.39

8.17

1.4

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

3.27

8.15

3.8

2.8

umol/l

59.2

47.3

0.97

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.08

8.14

1.2

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

224

1488

1.53

8.10

2.7

2.1

ml/min/173m2

83.1

84.6

0.25

512

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

148

892

1.68

8.03

1.9

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

193

2.50

7.99

2.9

3.1

mg/l

121.3

28.4

0.53

161

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.86

7.84

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.43

7.61

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

217

2.36

7.54

1.4

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1047

8894

1.23

7.50

4.2

2.9

estimate

0.0

2.88

403

3523

(3037121) Protein [Mass/volume] in Urine

125

737

1.71

7.38

2.4

3.5

g/l

0.2

0.4

1.38

337

(3011985) Renin [Units/volume] in Plasma

264

2.21

7.34

2.1

1.7

mu/l

81.6

83.3

0.01

241

(3030981) Hyaline casts [#/volume] in Urine by Automated count

164

1039

1.60

7.33

3.1

2.1

e6/l

0.3

0.2

0.46

157

989

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.34

7.33

1.2

—

(3036180) Methadone [Presence] in Urine

+∞

7.28

1.3

0.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

105

2.96

7.18

1.2

1.4

pmol/l

12.8

13.3

0.27

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

782

1.68

7.14

1.1

u/ml

3.7

2.5

0.54

430

(3024980) IgG subclass 4 [Mass/volume] in Serum

423

1.93

7.12

1.4

1.7

g/l

0.6

0.7

0.17

323

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.18

7.06

6.1

3.4

mg/l

56.4

6506.4

1.08

(3049717) Cytology report of Urine Cyto stain

282

2.14

7.03

1.9

2.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

263

2.18

7.00

1.4

1.2

nmol/l

0.5

0.03

257

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

120

712

1.70

6.95

1.1

1.3

u/ml

36.2

34.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

343

2544

1.38

6.93

1.3

1.2

u/ml

237.6

210.3

0.18

321

2350

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

164

1055

1.57

6.89

5.6

2.6

g/l

3.7

3.6

0.29

147

991

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

153

2.56

6.88

1.4

1.2

u/l

73.4

90.1

0.25

100

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

107

617

1.75

6.86

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.05

6.84

2.3

2.7

nmol/l

1.4

1.5

0.13

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

156

994

1.59

6.83

2.1

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

197

2.34

6.74

1.2

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

532

1.80

6.74

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

397

3029

1.34

6.69

1.3

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

144

2.58

6.64

2.4

2.3

61.0

53.4

1.39

(3024891) Influenza virus A+B Ag [Presence] in Specimen

153

978

1.58

6.62

1.2

1.1

—

(3000012) Reticulocyte production index

3.25

6.51

1.8

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

1102

1.54

6.50

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

452

1.85

6.46

2.6

2.2

g/l

132.6

132.3

0.06

361

(40757494) Bilirubin.total [Moles/volume] in Blood

3.50

6.39

2.1

2.8

umol/l

14.0

48.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

141

2.56

6.39

1.1

g/l

0.3

1.47

114

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

260

2.12

6.39

1.9

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

172

2.39

6.31

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

309

2.02

6.27

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

5.45

6.26

1.8

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

199

2.27

6.16

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

150

2.47

6.13

2.4

3.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

110

2.73

6.06

1.3

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

176

2.34

6.01

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

117

2.65

5.94

3.2

3.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

129

818

1.59

5.82

1.5

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

173

2.32

5.78

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

484

1.77

5.76

2.1

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

180

2.28

5.73

3.3

3.1

—

(3047181) Lactate [Moles/volume] in Blood

508

1.74

5.69

5.0

3.5

mmol/l

1.2

1.1

0.50

453

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

591

1.69

5.68

1.7

2.2

mg/l

10.4

9.8

0.45

559

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

593

1.68

5.61

1.4

1.2

u/ml

5.2

4.2

0.26

252

(3017732) Neutrophils [#/volume] in Blood

279

2074

1.37

5.60

2.4

1.7

e9/l

3.8

4.2

1.56

204

1797

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.10

5.57

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1392

0.59

5.56

1.6

mmol/l

7.1

7.4

0.49

852

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

235

2.09

5.53

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

242

2.07

5.51

1.3

1.4

pmol/l

504.3

445.5

0.34

199

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

209

2.16

5.51

2.0

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

425

1.80

5.49

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

236

2.08

5.47

1.4

1.2

—

(4306422)

101

613

1.66

5.46

1.1

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1463

13125

1.17

5.45

3.8

2.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

191

2.20

5.42

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

271

2.00

5.41

1.1

g/l

1.5

0.29

251

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

185

2.22

5.39

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

122

779

1.58

5.37

1.5

1.3

u/ml

97.4

105.8

0.51

171

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

136

2.43

5.32

1.1

nmol/l

0.1

8.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

143

2.38

5.25

1.4

1.7

nmol/l

1.1

2.4

1.50

109

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

+∞

5.20

1.4

0.0

nmol/l

148.8

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

5.20

2.4

0.0

nmol/l

72.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

497

1.70

5.02

1.2

1.1

iu/ml

108.3

2529.6

0.74

159

(3008898) HLA-B27 [Presence]

240

1774

1.37

5.01

1.1

—

(3012898) Urea [Moles/volume] in Urine

5.26

5.01

2.4

2.7

mmol/l

233.6

158.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

298

1.89

4.78

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.88

4.73

1.3

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

267

1.92

4.58

1.2

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

573

1.61

4.55

1.1

113.8

115.6

0.25

516

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

234

1.97

4.49

1.4

1.2

nmol/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.05

4.48

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.05

4.48

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.05

4.48

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

248

3218

0.75

4.48

1.3

—

(3017569) Oxygen content in Arterial blood

4.00

4.41

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

322

1.81

4.36

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

251

1.92

4.34

2.9

3.3

mmol/l

6.5

6.7

0.11

199

(4062490)

281

1.86

4.27

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

171

2.11

4.24

2.0

1.7

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.87

4.23

1.9

1.7

mg/l

2.5

5.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

314

1.79

4.10

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.47

4.09

2.2

1.6

u/l

5.1

3.1

0.38

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

301

1.80

4.04

2.3

2.8

ug/min

56.5

105.9

0.67

212

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.45

4.01

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.50

4.01

1.7

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

217

1.94

3.97

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

2.38

3.94

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

2.26

3.93

2.1

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.63

3.90

1.2

1.1

umol/24h

0.8

0.6

—

(3000034) Microalbumin [Mass/volume] in Urine

125

2.24

3.86

3.4

mg/l

36.6

77.4

0.63

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.26

3.85

6.8

5.7

mmol/l

3.7

6.7

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.26

3.85

1.5

2.5

—

(3025130) Human papilloma virus identified in Specimen

134

943

1.43

3.81

1.9

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

278

1.80

3.79

1.2

1.3

g/l

6.0

6.9

1.31

190

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.06

3.78

1.3

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

128

2.19

3.66

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

128

2.19

3.66

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

128

2.19

3.66

1.8

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.79

3.66

1.2

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

109

2.29

3.65

1.8

2.1

e6/l

314.1

236.7

0.33

(3037756) Immunofixation for Serum or Plasma

142

2.11

3.61

1.9

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1754

16281

1.13

3.58

4.2

3.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

277

1.77

3.54

1.2

1.3

g/l

2.9

3.0

0.28

189

(3024139) IgG subclass 3 [Mass/volume] in Serum

277

1.77

3.54

1.2

1.3

g/l

0.3

0.4

1.81

187

(3041096) Erythrocytes [Presence] in Urine by Automated

1125

10160

1.14

3.52

3.3

2.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

184

2401

0.75

3.50

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.29

3.50

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

206

1.90

3.49

1.8

2.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

431

1.61

3.46

1.8

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

222

1.85

3.41

2.0

2.3

45.3

45.4

—

(3011412) CD3 cells [#/volume] in Blood

266

1.77

3.40

1.8

2.5

e9/l

1.5

1.2

0.92

165

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

140

1016

1.39

3.38

1.8

2.3

iu/l

2.2

4.3

9.52

453

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

319

1.70

3.37

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

245

1.80

3.36

1.6

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

2.28

3.33

2.0

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

210

1.86

3.31

1.8

2.5

e6/l

597.4

499.3

0.93

175

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

175

1.94

3.30

1.9

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

182

1.92

3.30

1.9

2.7

e6/l

880.7

822.7

0.16

(3001556) Androgen free Index in Serum or Plasma

109

2.20

3.22

1.3

1.1

—

(40761536) Microorganisms panel - Urine sediment

390

3255

1.21

3.22

4.0

2.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

649

1.47

3.21

1.4

1.2

u/ml

3.8

4.1

0.08

241

(3005011) Chlamydia sp Ab [Titer] in Serum

2.66

3.20

1.6

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

206

1.85

3.17

1.8

2.6

e9/l

0.2

0.19

175

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

418

0.45

3.17

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.85

3.17

1.1

—

(3000492) Spirometry study

353

2926

1.22

3.13

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

2.46

3.10

55.4

33.2

ug/l

7.6

7.1

0.42

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

215

1.82

3.10

1.4

1.8

—

(4034850)

100

696

1.44

3.08

8.9

5.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

180

1.89

3.06

1.1

1.2

u/l

36.4

31.3

0.07

152

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

918

0.64

3.05

1.5

1.6

mmol/l

6.3

6.4

0.16

636

(3035947) Staphylolysin Ab [Units/volume] in Serum

2.32

3.05

1.0

1.1

iu/ml

—

4.5

—

(44806071)

2.68

3.03

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.22

3.03

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.44

3.03

1.2

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

560

1.49

3.01

2.8

3.4

56.9

55.4

0.49

560

(44813793)

316

1.65

2.96

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

2.94

1.0

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

547

1.49

2.93

2.7

3.2

e9/l

4.2

3.8

0.71

547

(3041806) Other cells [#/volume] in Blood by Manual count

606

1.46

2.89

1.5

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1318

0.70

2.89

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.08

2.87

1.0

1.2

—

(3025315) Body weight

5.37

2.86

3.1

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.50

2.85

2.2

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

382

1.57

2.84

1.1

83.0

91.0

1.37

361

(3038026) Centromere Ab [Units/volume] in Serum

186

1.83

2.80

1.1

1.3

—

44.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

433

1.53

2.75

1.9

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

8.31

2.74

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.31

2.72

1.3

—

18.0

—

(3022689) Creatine [Moles/volume] in Urine

2.70

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.59

2.68

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

4.20

2.67

1.4

1.2

mmol/l

0.9

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

3.74

2.66

1.6

8.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

704

7824

0.88

2.65

1.6

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.12

2.63

3.6

1.4

mmol/l

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.33

2.63

1.3

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

359

1.56

2.61

1.1

—

(3042733) HLA Ab [Presence] in Serum

2.54

2.59

5.5

4.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

297

1.62

2.59

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.30

2.55

1.4

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

5.44

2.53

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

223

1.71

2.50

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

223

1.71

2.50

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

220

1781

1.24

2.49

2.0

2.3

umol/l

5.8

5.1

0.17

159

1325

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

163

2056

0.78

2.48

2.0

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

601

1.42

2.48

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.38

2.44

2.3

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.66

2.43

2.3

4.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

227

1.67

2.37

1.7

2.2

9.4

11.5

0.82

126

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

540

1.43

2.36

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

1045

1.31

2.36

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.75

2.36

1.2

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

313

1.57

2.35

1.1

1.2

ratio

1.0

0.03

129

(3017704) Immunofixation for Urine

2.85

2.29

1.8

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.47

2.26

2.9

3.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.06

2.25

3.2

5.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

273

2289

1.20

2.22

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.10

2.21

2.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

143

1.82

2.16

1.2

1.1

u/ml

3.2

7.0

0.48

100

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

312

1.54

2.16

1.2

mg/l

34.1

39.8

0.24

250

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.24

2.15

2.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

136

1.84

2.15

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

4.28

2.14

1.7

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

189

1.69

2.11

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

379

1.48

2.09

2.7

4.4

u/ml

38.2

80.0

—

131

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

123

1.87

2.09

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.70

2.09

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.70

2.09

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

404

1.46

2.08

3.6

2.6

—

(3045414) Leukocytes [Presence] in Urine

168

1350

1.25

2.08

2.0

1.6

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

4.99

2.06

1.6

1.0

u/l

104.0

60.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

148

1173

1.27

2.06

1.5

1.3

—

(4027681)

260

1.58

2.06

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

198

1.67

2.06

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

131

1.83

2.05

2.1

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

159

0.38

2.01

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.63

1.99

1.7

1.2

—

(3024471) HLA-A [Type]

2.22

1.99

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.22

1.99

2.0

2.2

—

(3024932) HLA-DR beta [Type]

2.22

1.99

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

1.98

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.33

1.95

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.33

1.95

1.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.53

1.93

1.8

1.1

—

(1761868) Lipid panel - Serum or Plasma

1165

12391

0.91

1.93

2.2

1.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.11

1.90

2.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.00

1.88

2.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.00

1.88

2.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.00

1.88

2.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.00

1.88

2.2

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1469

13855

1.09

1.86

1.9

1.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

284

1.51

1.84

2.3

u/ml

13.6

6.8

0.47

214

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

341

1.47

1.84

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

182

1.65

1.82

1.7

1.4

—

(3002256) Pathology report gross observation

384

3372

1.15

1.82

1.2

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.16

1.82

1.0

u/ml

0.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.04

1.79

1.0

—

(3045424) Erythrocytes [Presence] in Urine

495

1.38

1.76

1.7

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.33

1.74

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.33

1.74

1.7

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

0.47

1.72

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

2.66

1.71

2.1

1.9

—

(3047189) Immunofixation for 24 hour Urine

2.66

1.71

1.4

1.7

—

(3023419) Bacteria identified in Sputum by Culture

125

1.76

1.70

2.5

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.06

1.68

2.8

3.1

nmol/l

1.1

0.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

210

1.57

1.68

1.6

mg/l

31.9

31.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

629

1.32

1.68

1.4

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

172

1.63

1.65

1.0

1.2

83.6

102.1

—

(40768441) Liver Pathology biopsy report

157

1.65

1.63

1.1

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

1.78

1.62

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.24

1.62

1.3

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.32

1.59

1.4

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.06

1.58

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

451

4985

0.89

1.58

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.90

1.58

1.0

1.1

u/ml

0.0

1.4

2.43

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.90

1.58

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

1.69

1.57

4.2

2.2

—

(4268621)

430

1.37

1.55

2.6

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

144

1.67

1.55

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

330

1.42

1.53

2.0

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

264

1.48

1.53

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.03

1.52

1.0

1.1

—

(3051339) Copper [Moles/volume] in Blood

3.33

1.52

1.4

1.1

umol/l

18.1

18.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

200

1.55

1.51

1.2

1.1

u/ml

219.8

9.4

0.47

119

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

216

1.53

1.51

1.0

1.1

u/l

1.1

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

306

1.44

1.51

1.1

mg/l

203.1

202.2

0.01

267

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

273

1.46

1.51

1.1

iu/ml

6.1

4.7

0.15

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.85

1.50

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

184

0.49

1.50

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.86

1.48

1.0

u/ml

0.0

0.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

309

1.42

1.45

1.0

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.72

1.43

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1.91

1.42

1.3

1.5

e6/l

1344.1

1796.7

—

(3021788) Differential panel - Synovial fluid

302

1.42

1.9

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.97

1.42

1.2

1.0

—

176.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

172

1.57

1.41

1.1

—

(3000330) Specific gravity of Urine by Test strip

135

1114

1.21

1.40

3.1

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

137

0.44

1.39

1.7

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.19

1.36

1.1

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.60

1.36

1.0

1.2

umol/24h

1.6

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.60

1.36

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.60

1.36

6.2

4.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

704

1.27

1.36

1.2

1.1

au/ml

15.7

9.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1166

11017

1.08

1.36

1.6

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.77

1.31

24.8

29.8

ug/l

156.9

121.9

0.57

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

176

1.53

1.29

1.0

1.1

92.0

99.1

—

(3014051) Protein [Presence] in Urine by Test strip

684

1.26

1.27

2.3

1.8

—

(3013637) Mi-2 Ab [Presence] in Serum

2.08

1.26

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.08

1.26

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.08

1.26

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.08

1.26

1.1

—

(3044927) Protein electrophoresis panel - Urine

1.85

1.22

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

1.90

1.21

1.3

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

155

1.55

1.21

1.3

—

(3034426) Prothrombin time (PT)

116

1.64

1.20

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

421

4591

0.90

1.19

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

424

4618

0.91

1.17

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.87

1.17

1.3

1.5

e6/l

10234.2

18991.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

424

4615

0.91

1.16

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

1.15

0.0

1.3

—

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

4610

0.91

1.14

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.84

1.12

2.6

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.84

1.12

2.6

1.8

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.00

1.11

1.1

u/ml

2.0

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.89

1.11

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.25

1.10

22.9

6.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.25

1.10

2.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.78

1.09

1.3

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.78

1.09

1.3

2.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

1.07

1.3

1.0

—

(40768806) Pleura Pathology biopsy report

1.79

1.03

1.2

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.79

1.03

2.7

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

236

2101

1.13

1.01

1.3

1.2

ug/l

3.8

3.7

0.13

228

2018

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

221

1960

1.13

1.00

1.6

2.2

u/ml

21.1

34.3

3.36

214

1899

(3029396) Erythrocyte agglutination [Presence] in Blood

436

0.73

1.00

3.4

3.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

0.99

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

737

0.79

0.98

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

1168

1.17

0.98

1.1

u/ml

6.0

7.3

0.34

683

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.17

0.97

1.0

—

(3044941) Cell count panel - Synovial fluid

240

1.37

0.96

1.6

1.4

—

(3004451) EKG impression Narrative

1.94

0.96

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.80

0.96

1.3

1.1

—

(3020491) Glucose [Moles/volume] in Blood

266

1.35

0.96

1.7

1.6

mmol/l

5.2

5.6

1.36

231

(3038177) Helicobacter pylori Ab [Presence] in Serum

702

1.21

0.95

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1017

0.83

0.95

1.7

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

116

0.51

0.94

1.5

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

174

1.43

0.93

2.2

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.66

0.90

2.0

3.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

348

1.29

0.90

2.0

1.8

e6/l

23307.0

8570.0

0.78

270

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.62

0.89

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

284

3105

0.91

0.89

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.57

0.89

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.06

0.89

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.99

0.86

24.3

6.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

254

1.34

0.86

1.2

u/ml

0.5

0.4

0.05

(3012565) Volume of 24 hour Urine

1.61

0.86

1.6

2.1

1933.3

1984.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.81

0.85

2.1

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

136

1.47

0.85

1.8

2.6

42.3

45.0

—

(40768795) Lymph node Pathology biopsy report

203

0.64

0.85

1.5

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

630

1.21

0.85

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1.36

0.84

1.9

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

128

1112

1.15

0.83

1.1

u/ml

1.0

1.2

0.30

531

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.73

0.82

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.57

0.80

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

132

1158

1.14

0.76

1.1

u/ml

1.4

2.7

0.77

310

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.69

0.75

7.0

3.8

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.08

0.74

1.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.52

0.71

1.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

379

1.24

0.71

1.7

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.75

0.71

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.54

0.71

1.0

1.1

u/ml

0.1

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.58

0.70

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1441

14779

0.96

0.70

1.8

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

157

0.63

0.69

5.9

3.7

u/ml

43.3

42.7

—

157

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

169

1.36

0.68

1.9

2.5

mg/l

10.2

10.3

0.02

143

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.64

0.67

2.7

2.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

311

2883

1.08

0.66

1.4

1.3

miu/ml

202.5

235.0

0.90

134

1561

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.51

0.65

1.1

1.0

u/ml

0.2

9.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

100

873

1.15

0.65

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

188

1.33

0.65

1.4

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

359

0.78

0.64

2.8

3.6

u/ml

18.3

21.8

0.46

346

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.57

0.64

1.2

1.4

ug/l

10.7

8.0

0.58

(4281824)

257

0.74

0.63

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

970

1.13

0.62

1.1

u/ml

3.9

4.9

0.17

406

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.49

0.62

1.0

u/ml

0.5

0.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

101

0.59

0.62

1.0

1.4

—

(3022621) pH of Urine by Test strip

222

2036

1.09

0.62

2.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.66

0.61

1.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

711

1.15

0.60

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

182

1.32

0.60

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

316

1.23

0.59

1.8

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

2.2

—

2.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.53

0.59

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

101

890

1.13

0.59

1.1

u/ml

4.3

5.9

0.37

408

(3042631) Mycobacterium sp identified in Specimen

105

1.43

0.59

2.1

2.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

105

931

1.13

0.56

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

931

1.13

0.56

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

613

1.16

0.56

3.9

2.8

mg/l

17.9

24.4

0.83

374

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.62

0.55

1.8

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

203

1.28

0.54

1.5

1.2

—

(3015183) Erythrocyte sedimentation rate

283

0.77

0.54

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

1.47

0.53

1.3

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.41

0.53

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

1346

1.10

0.52

1.2

1.1

u/ml

0.9

2.2

2.21

565

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

259

1.23

0.51

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

873

1.12

0.51

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

433

0.83

0.51

1.0

1.1

u/ml

47.1

2.1

0.46

113

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.38

0.50

1.7

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

279

0.78

0.49

1.0

1.1

miu/ml

1986.1

1398.4

1.30

279

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.44

0.47

1.0

u/ml

0.0

0.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

396

0.83

0.46

1.0

u/ml

0.3

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.40

0.45

1.3

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.61

0.43

1.2

2.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.56

0.42

1.0

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.41

0.0

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

350

1.17

0.41

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

227

0.79

0.41

1.4

1.3

g/l

0.9

0.13

227

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

185

1.24

0.41

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.40

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.33

0.40

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.40

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

195

2072

0.93

0.40

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.39

0.0

3.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1336

13056

1.03

0.38

1.9

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

269

1.19

0.38

1.6

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

132

1219

1.08

0.37

3.7

ug/l

1.4

1.9

1.24

110

1106

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

510

0.88

0.35

1.4

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.39

0.35

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

719

0.90

0.34

2.5

ug/l

0.5

0.7

3.49

383

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

766

1.09

0.33

1.1

1.0

u/ml

0.1

0.2

0.49

156

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

154

1.23

0.33

1.6

2.6

ug/l

21.9

195.2

0.72

146

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.68

0.33

3.7

2.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

409

1.12

0.29

1.2

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

968

0.93

0.28

3.7

3.4

20.9

21.3

0.06

362

(44790049)

250

1.16

0.28

1.3

1.6

—

(44790047)

250

1.16

0.28

1.3

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

449

1.11

0.27

1.2

1.3

—

(44790048)

251

1.15

0.27

1.3

1.6

—

(44806118)

251

1.15

0.27

1.3

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.19

0.26

1.1

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.26

0.25

1.0

—

(40768793) Breast Pathology biopsy report

724

0.92

0.25

1.2

1.3

—

(3024263) Appearance of Synovial fluid

1.18

0.24

1.6

2.3

—

(4035726)

162

1538

1.05

0.24

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

417

1.10

0.23

1.0

1.1

u/ml

0.4

3.2

2.05

130

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.25

0.22

1.0

1.2

—

(40768446) Kidney Pathology biopsy report

1.26

0.21

2.2

1.3

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

2.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

116

1.20

0.21

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

23.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

525

1.08

0.21

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

166

0.84

0.21

1.9

u/field

2.4

2.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.22

0.20

1.7

2.3

—

(4038314)

0.00

0.20

0.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.15

0.19

1.2

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

185

0.86

0.18

6.8

7.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.22

0.18

2.4

1.7

—

(3005033) Fetal Nuchal fold Thickness US

359

3662

0.97

0.17

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

110

1.18

0.16

1.0

1.2

—

(4211845)

205

1.12

0.16

2.3

2.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.12

0.16

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

410

0.92

0.16

1.3

1.1

—

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

206

1.11

0.15

3.8

3.4

mg/l

7.7

7.9

0.06

174

(3047352) Trisomy 18 risk [Likelihood] in Fetus

361

3670

0.98

0.14

1.5

—

(21494434) Karyotype in Bone marrow

103

1.16

0.13

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

106

0.85

0.13

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

106

0.85

0.13

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

106

0.85

0.13

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3320

33004

1.01

0.12

4.4

4.0

—

(3045142) Bone marrow Pathology biopsy report

142

1.12

0.12

1.1

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

415

1.06

0.10

3.1

3.4

u/ml

83.2

414.3

0.51

362

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

1121

0.97

0.10

1.8

1.6

iu/ml

0.0

0.5

1.94

211

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

686

0.96

0.10

1.5

mmol/l

11.6

0.01

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

106

1.13

0.09

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

371

3747

0.99

0.09

1.5

—

(40758292) HTLV I+II Ab panel - Serum

1.09

0.08

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

155

1.09

0.08

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

205

0.92

0.08

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.80

0.08

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.80

0.08

6.2

2.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.07

0.08

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

214

1.07

0.08

2.5

1.8

58.1

47.1

0.60

144

(4094501)

361

1.05

0.07

1.0

1.1

—

(4024509)

244

0.94

0.07

2.0

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

878

0.98

0.06

1.4

nmol/l

32.6

34.0

0.15

816

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

591

5932

0.99

0.06

2.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

187

1.07

0.06

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

116

1176

0.98

0.05

2.5

3.7

ug/l

28.5

44.2

0.15

788

(40765089) Chromosome analysis panel - Blood by G-banded

318

0.97

0.02

1.0

—

(3020650) Glucose [Presence] in Urine

137

0.95

0.02

1.6

1.3

—

(3006462) Nitrate [Presence] in Urine

186

1.02

0.00

2.5

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

178

1.01

0.00

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

335

1.01

0.00

2.4

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

103

0.97

0.00

2.0

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.6

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.1

—

92.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

9.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.4

—

0.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.00

0.00

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

135.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3001729) Color of Synovial fluid

0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.5

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

101.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.3

—

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.6

—

56.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_EATING_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_EATING_EXMORE	2.861 [2.39, 3.42]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.22

During the follow-up period (1.1.1998 — 31.12.2019), 901 out of 25614 females with KRA_PSY_EATING_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_EATING_EXMORE	3.236 [2.57, 4.08]	< 0.001
Birth year	0.984 [0.97, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 506 out of 3356 males with KRA_PSY_EATING_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_EATING_EXMORE.

N-year risk	Females	Males
1	0.277%	0.613%
5	1.664%	3.669%
10	4.01%	8.729%
15	7.985%	15.408%
20	13.555%	25.088%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_EATING_EXMORE – KRA_PSY_EATING, excluding more controls

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

KRA_PSY_EATING, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints